(Q35607675)

English

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

scientific article published on 20 October 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andrew M. Wardley

object named as

Andrew Wardley

10

0 references

5

object named as

Bent Ejlertsen

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

2

object named as

Patrick Neven

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Eva Sedláčková

1 reference

ORCID Public Data File 2021

Aron Goldhirsch

4

object named as

Aron Goldhirsch

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Manuela Rabaglio

11

object named as

Manuela Rabaglio

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Beat Thürlimann

15

object named as

Beat Thürlimann

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Anita Giobbie-Hurder

3

object named as

Anita Giobbie-Hurder

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Meredith M Regan

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Louis Mauriac

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

John F Forbes

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Ian Smith

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

István Láng

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Karen N Price

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Richard D Gelber

13

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Alan S Coates

14

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

BIG 1-98 Collaborative Group

16

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

International Breast Cancer Study Group (IBCSG)

17

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

20 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1101-1108

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Stopping treatment can reverse acquired resistance to letrozole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Annual hazard rates of recurrence for breast cancer after primary therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

12 July 2018

Correcting for discretionary treatment crossover in an analysis of survival in the Breast International Group BIG 1-98 trial by using the inverse probability of censoring weighted method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

25 September 2018

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

25 September 2018

The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

25 September 2018

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235950

25 September 2018

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22018631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of women in trials of adjuvant therapy for breast cancer: is it still important?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22018631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

1 reference

https://pubmed.ncbi.nlm.nih.gov/22018631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22018631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970270-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of health care delivered to adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970270-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(11)70270-4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35607675&oldid=2057299398"